Table 2.
Characteristics of the study population for statin users (January 2005 to July 2013)
| Total | Male | Female | |||
|---|---|---|---|---|---|
| Users, n | 95,941 | ||||
| Claims including statins, n | 1,624,438 | ||||
| Incident users , n (%) | 38,402 | 22,708 (59.1) | 15,694 (40.9) | ||
| Age, years, n (%) | |||||
| <20 | 78 (0.20) | 39 (0.17) | 39 (0.25) | ||
| 20-39 | 4,696 (12.2) | 3,753 (16.5) | 943 (6.01) | ||
| 40-59 | 24,757 (64.0) | 14,674 (64.6) | 10,083 (64.3) | ||
| 60-79 | 8,790 (22.9) | 4,234 (18.7) | 4,556 (29.0) | ||
| ≧80 | 81 (0.21) | 8 (0.04) | 73 (0.47) | ||
| Mean ±SD | 51.8±10.4 | 49.8±10.1 | 54.8±10.0 |
Incident users: Number of patients who received their first prescription for statins
SD: Standard deviation